CORRIGENDUM TO EGM TO BE HELD ON 12.02.2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Godavari Drugs has issued a corrigendum to the notice of its 1st EGM of FY2025-26, which is scheduled for 12 February 2026 at 11:00 a.m. via video conferencing. The EGM will seek shareholder approval for a preferential issue of 23,60,065 convertible warrants to promoters and 25,96,935 equity shares to promoter and non-promoter allottees at Rs. 89 per share. BSE flagged an observation on the original notice, and the company found that one proposed allottee (Kakani Bros) already holds 24,000 shares (0.32%) before the issue, which was previously omitted. The corrigendum updates pre-issue and post-issue shareholding disclosures for all 31 proposed allottees accordingly; all other EGM agenda items remain unchanged.
No major change for existing shareholders — this is a procedural correction to disclosure, not a revision to the fundraising size or pricing. Shareholders should review the updated pre-issue holding of Kakani Bros before voting on the preferential issue, which could result in promoter warrant conversions and equity dilution upon approval.